Tag Archives: Ben Klieve

National Securities Corp Keeps a Buy Rating on Bioceres Crop Solutions (BIOX)

In a report released today, Ben Klieve from National Securities Corp maintained a Buy rating on Bioceres Crop Solutions (BIOX – Research Report), with a price target of $12.00. The company’s shares closed last Thursday at $5.69. Klieve has an

National Securities Corp Sticks to Its Buy Rating for Limoneira Co (LMNR)

In a report released today, Ben Klieve from National Securities Corp reiterated a Buy rating on Limoneira Co (LMNR – Research Report), with a price target of $20.00. The company’s shares closed last Wednesday at $14.92. According to TipRanks.com, Klieve

Raven (RAVN) Receives a Buy from National Securities Corp

National Securities Corp analyst Ben Klieve maintained a Buy rating on Raven (RAVN – Research Report) today and set a price target of $30.00. The company’s shares closed last Wednesday at $24.33. Klieve has an average return of 19.3% when

Analyst Explains Why They Upgraded Their Rating on Yield10 Bioscience (YTEN)

Yield10 Bioscience (YTEN – Research Report) received a Buy rating and a $15.00 price target from National Securities Corp analyst Ben Klieve today. The company’s shares closed last Wednesday at $4.79, close to its 52-week low of $3.50. According to

National Securities Corp Initiates a Buy Rating on The Andersons (ANDE)

National Securities Corp analyst Ben Klieve initiated coverage with a Buy rating on The Andersons (ANDE – Research Report) today and set a price target of $24.00. The company’s shares closed last Tuesday at $17.84. According to TipRanks.com, Klieve is

AquaBounty Technologies (AQB) Receives a Buy from National Securities Corp

In a report released today, Ben Klieve from National Securities Corp maintained a Buy rating on AquaBounty Technologies (AQB – Research Report), with a price target of $5.00. The company’s shares closed last Friday at $2.98. Klieve has an average